Proteins and bioactive peptides: Mechanisms of action on diabetes management
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus (T2DM) is a major metabolic, multi-causal and heterogeneous disorder, characterised by chronic hyperglycaemia, which causes significant morbidity and mortality, with a considerable burden on health-care resources. The number of deaths due to T2DM highlights the importance of controlling the disease and its complications. It has been demonstrated that some proteins, protein hydrolysates, bioactive peptides and amino acids can control glucose levels directly or indirectly. Bioactive peptides have been identified in a range of food ingredients and offer the potential for incorporation into functional and nutraceutical foods. In this review, we discuss the possible mechanisms by which these compounds exert their action on glucose control such as modulating insulin production, incretin secretion, dipeptidyl peptidase-4 inhibition, regulation of glucose uptake in peripheral tissue and inhibition of some enzymes related with glucose absorption. Peptides such as IPAVF, PGVGGPLGPIGPCYE, CAYQWQRPVNRIR, PACGGFYISGRPG, WV, GPAE, GPGA, LP, IP, KLPGF and LI have shown potential for regulating blood glucose. Bioavailability and delivery of bioactive peptides are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60613-9 · Cited by 1,301
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Nilsson, M., Holst, J. J., & Björck, I. M. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.996 · Cited by 374
Cited by
Generation of bioactive peptides during food processing
Toldrá, F., Reig, M., Aristoy, M.-C., & Mora, L. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2017.06.119 · Cited by 317
Milk proteins as a source of tryptophan-containing bioactive peptides
Nongonierma, A. B., & FitzGerald, R. J. (2015) · Food & Function · doi:10.1039/c5fo00407a · Cited by 83
McLaughlin, C. M., Harnedy-Rothwell, P. A., Lafferty, R. A., Sharkey, S., Parthsarathy, V., Allsopp, P. J., McSorley, E. M., FitzGerald, R. J., & O’Harte, F. P. M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02583-3 · Cited by 45
Chawla, I., Dhanawat, M., Sharma, M., & Gupta, S. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998275676240202065952 · Cited by 2
Metadata
- Authors
- Oseguera-Toledo, M. E., González de Mejía, E., Reynoso-Camacho, R., Cardador-Martínez, A., & Amaya-Llano, S. L.
- Venue
- Nutrafoods
- Published
- 2014-12
- Volume
- 13
- Issue
- 4
- Pages
- 147-157
- ISSN
- 1827-8590 (ISSN-L)
- 2240-5291
- OpenAlex
- W248559455
- Cited by
- 50
- References
- 5
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteins and bioactive peptides: Mechanisms of action on diabetes management. https://app.cochat.ai/papers/10.1007/s13749-014-0052-z
- The paper
- Oseguera-Toledo, M. E., González de Mejía, E., Reynoso-Camacho, R., Cardador-Martínez, A., & Amaya-Llano, S. L. (2014). Proteins and bioactive peptides: Mechanisms of action on diabetes management. Nutrafoods. https://doi.org/10.1007/s13749-014-0052-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.